168 related articles for article (PubMed ID: 30612055)
1. Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron.
Haney SL; Varney ML; Safranek HR; Chhonker YS; G-Dayanandan N; Talmon G; Murry DJ; Wiemer AJ; Wright DL; Holstein SA
Leuk Res; 2019 Feb; 77():17-27. PubMed ID: 30612055
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the activity of a novel tropolone in osteosarcoma.
Haney SL; Feng D; Kollala SS; Chhonker YS; Varney ML; Williams JT; Ford JB; Murry DJ; Holstein SA
Drug Dev Res; 2024 Feb; 85(1):e22129. PubMed ID: 37961833
[TBL] [Abstract][Full Text] [Related]
3. Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells.
Haney SL; Allen C; Varney ML; Dykstra KM; Falcone ER; Colligan SH; Hu Q; Aldridge AM; Wright DL; Wiemer AJ; Holstein SA
Oncotarget; 2017 Sep; 8(44):76085-76098. PubMed ID: 29100294
[TBL] [Abstract][Full Text] [Related]
4. Effects of iron chelators, iron salts, and iron oxide nanoparticles on the proliferation and the iron content of oligodendroglial OLN-93 cells.
Hohnholt M; Geppert M; Dringen R
Neurochem Res; 2010 Aug; 35(8):1259-68. PubMed ID: 20467895
[TBL] [Abstract][Full Text] [Related]
5. Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis.
Li J; Falcone ER; Holstein SA; Anderson AC; Wright DL; Wiemer AJ
Pharmacol Res; 2016 Nov; 113(Pt A):438-448. PubMed ID: 27663262
[TBL] [Abstract][Full Text] [Related]
6. Protection by tropolones against H2O2-induced DNA damage and apoptosis in cultured Jurkat cells.
Doulias PT; Nousis L; Zhu BZ; Frei B; Galaris D
Free Radic Res; 2005 Feb; 39(2):125-35. PubMed ID: 15763960
[TBL] [Abstract][Full Text] [Related]
7. Effect of ferrous and ferric chelators on transferrin-iron-macrophage interactions.
Baynes RD; Friedman BM; Bukofzer GT; Bothwell TH; Macfarlane BJ; Lamparelli RD
Am J Hematol; 1988 Sep; 29(1):27-32. PubMed ID: 3177366
[TBL] [Abstract][Full Text] [Related]
8. Effect of cellular iron concentration on iron uptake by hepatocytes.
Trinder D; Batey RG; Morgan EH; Baker E
Am J Physiol; 1990 Oct; 259(4 Pt 1):G611-7. PubMed ID: 2221071
[TBL] [Abstract][Full Text] [Related]
9. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
Rodríguez JA; Luria-Pérez R; López-Valdés HE; Casero D; Daniels TR; Patel S; Avila D; Leuchter R; So S; Ortiz-Sánchez E; Bonavida B; Martínez-Maza O; Charles AC; Pellegrini M; Helguera G; Penichet ML
Leuk Lymphoma; 2011 Nov; 52(11):2169-78. PubMed ID: 21870996
[TBL] [Abstract][Full Text] [Related]
10. Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate.
Hoepken HH; Korten T; Robinson SR; Dringen R
J Neurochem; 2004 Mar; 88(5):1194-202. PubMed ID: 15009675
[TBL] [Abstract][Full Text] [Related]
11. Iron chelators induce autophagic cell death in multiple myeloma cells.
Pullarkat V; Meng Z; Donohue C; Yamamoto VN; Tomassetti S; Bhatia R; Krishnan A; Forman SJ; Synold TW
Leuk Res; 2014 Aug; 38(8):988-96. PubMed ID: 24998390
[TBL] [Abstract][Full Text] [Related]
12. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
13. Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
Lee DH; Jang PS; Chung NG; Cho B; Jeong DC; Kim HK
Exp Hematol; 2013 Jun; 41(6):539-46. PubMed ID: 23415674
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.
Jiang XP; Wang F; Yang DC; Elliott RL; Head JF
Anticancer Res; 2002; 22(5):2685-92. PubMed ID: 12529982
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.
Tanaka T; Satoh T; Onozawa Y; Kohroki J; Itoh N; Ishidate M; Muto N; Tanaka K
Cell Biol Int; 1999; 23(8):541-50. PubMed ID: 10704238
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
[TBL] [Abstract][Full Text] [Related]
17. Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells.
Kim JL; Lee DH; Na YJ; Kim BR; Jeong YA; Lee SI; Kang S; Joung SY; Lee SY; Oh SC; Min BW
Tumour Biol; 2016 Jul; 37(7):9709-19. PubMed ID: 26803514
[TBL] [Abstract][Full Text] [Related]
18. Iron Chelator Induces Apoptosis in Osteosarcoma Cells by Disrupting Intracellular Iron Homeostasis and Activating the MAPK Pathway.
Xue Y; Zhang G; Zhou S; Wang S; Lv H; Zhou L; Shang P
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281233
[TBL] [Abstract][Full Text] [Related]
19. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake.
Wardrop SL; Richardson DR
Eur J Biochem; 1999 Jul; 263(1):41-9. PubMed ID: 10429185
[TBL] [Abstract][Full Text] [Related]
20. The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
Lui GY; Obeidy P; Ford SJ; Tselepis C; Sharp DM; Jansson PJ; Kalinowski DS; Kovacevic Z; Lovejoy DB; Richardson DR
Mol Pharmacol; 2013 Jan; 83(1):179-90. PubMed ID: 23074173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
